13F-HR filed by GREAT POINT PARTNERS LLC
GREAT POINT PARTNERS LLC filed this 13F-HR for the quarter ended 2014-03-31, filed 2014-05-15, with 36 holding rows worth $191,481,000.
- Accession
- 0000930413-14-002534
- Filer
- CIK 1281446
- Filed
- 2014-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2014
A holdings report, 38 entries on the cover page, a total value of $191,481,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $191,481,000 with VALUE read as thousands by filing date, 13F file number 028-11743. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerJAY JEFFREY R028-12517
- included managerKROIN DAVID028-13262
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| FURIEX PHARMACEUTICALS | 36106P101 | COM | 205,858 | $17,910,000 | thousands by filing date | |
| HYPERION THERAPEUTICS INC | 44915N101 | COM | 493,751 | $12,739,000 | thousands by filing date | |
| PAIN THERAPEUTICS INC | 69562K100 | COM | 2,287,279 | $12,580,000 | thousands by filing date | |
| ALIMERA SCIENCES INC | 016259103 | COM | 1,500,000 | $11,835,000 | thousands by filing date | |
| DERMA SCIENCES INC | 249827502 | COM PAR $.01 | 925,000 | $11,729,000 | thousands by filing date | |
| OXYGEN BIOTHERAPEUTICS INC | 69207P308 | COM PAR $0.0001 | 2,000,000 | $11,100,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 620,000 | $9,982,000 | thousands by filing date | |
| ORTHOFIX INTL N V | N6748L102 | COM | 265,000 | $7,990,000 | thousands by filing date | put |
| ORTHOFIX INTL N V | N6748L102 | COM | 250,000 | $7,538,000 | thousands by filing date | |
| AMBIT BIOSCIENCES CORP | 02318X100 | COM | 719,261 | $6,560,000 | thousands by filing date | |
| INFINITY PHARMACEUTICALS INC | 45665G303 | COM | 500,400 | $5,950,000 | thousands by filing date | |
| VOLCANO CORPORATION | 928645100 | COM | 300,000 | $5,913,000 | thousands by filing date | |
| Alcobra Ltd | M2239P109 | SHS | 293,610 | $5,329,000 | thousands by filing date | |
| VERACYTE INC COM | 92337F107 | Stock | 310,248 | $5,315,000 | thousands by filing date | |
| SOPHIRIS BIO INC F | 83578Q209 | FOREIGN CANADIAN | 1,500,000 | $4,995,000 | thousands by filing date | |
| ANTHERA PHARMACEUTCLS INC | 03674U201 | Common equity shares | 1,369,237 | $4,587,000 | thousands by filing date | |
| AVEO PHARMACEUTICALS INC | 053588109 | COM | 2,866,483 | $4,285,000 | thousands by filing date | |
| SOCIETAL CDMO INC | 75629F109 | COM | 580,000 | $4,246,000 | thousands by filing date | |
| SUNSHINE HEART INC | 86782u106 | COM | 727,000 | $4,246,000 | thousands by filing date | |
| PROTALIX BIOTHERAPEUTICS INC | 74365A101 | COM | 912,155 | $4,178,000 | thousands by filing date | |
| CARA THERAPEUTICS INC | 140755109 | COM | 178,065 | $3,314,000 | thousands by filing date | |
| OCERA THERAPEUTICS INC COM | 67552A108 | COM | 311,821 | $3,290,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 315,000 | $2,993,000 | thousands by filing date | |
| ONCOTHYREON INC | 682324108 | COM | 991,800 | $2,965,000 | thousands by filing date | |
| NANOSPHERE INC | 63009F105 | COM | 1,280,309 | $2,753,000 | thousands by filing date | |
| DIPEXIUM PHARMACEUTICALS INC | 25456J104 | COM | 250,000 | $2,520,000 | thousands by filing date | |
| MANNKIND CORP | 56400P201 | COM | 546,900 | $2,199,000 | thousands by filing date | |
| MANNKIND CORP | 56400P201 | COM | 527,000 | $2,119,000 | thousands by filing date | call |
| MEI PHARMA INC | 55279B202 | COM NEW | 157,661 | $1,755,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 249,700 | $1,656,000 | thousands by filing date | |
| ONCOGENEX PHARMACEUTICALS IN | 68230A106 | COM | 130,000 | $1,529,000 | thousands by filing date | call |
| KALOBIOS PHARMACEUTICALS INC | 48344T100 | COM | 536,894 | $1,455,000 | thousands by filing date | |
| SUNESIS PHARMACEUTICALS INC | 867328601 | COM NEW | 193,567 | $1,279,000 | thousands by filing date | |
| PSIVIDA CORP | 74440J101 | COM | 283,313 | $1,162,000 | thousands by filing date | |
| STREAMLINE HEALTH SOLUTIONS | 86323X106 | COM | 151,611 | $763,000 | thousands by filing date | |
| MOMENTA PHARMACEUTICALS INC | 60877T100 | COM | 62,000 | $722,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000930413-14-002534 | this filing | 2014-05-15 | acceptance time not in the bulk data set |